MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Inhibition of mitochondrial complexes induces unique transcriptomic and epigenetic profiles: implications to neurodegeneration induced movement disorders

    R. Sathyanarayanan, S. Bharath (Bangalore, India)

    Objective: To compare the neurotoxicological hallmarks induced by inhibitors of mitochondrial complex I (CI- 1- methyl-4- phenylpyridinium; MPP+), complex II (CII- 3- nitropropionic acid; 3-…
  • 2019 International Congress

    Utility of a smartphone app in discretely assessing and monitoring symptoms of Parkinson’s disease

    N. Shaafi Kabiri, A. Best, S. Johnson, B. Ho, G. Eden, B. Dupee, M. Fedorovsky, J. Severson, D. Amato, B. Severson, J. Bhangu, J. Cosman, M. Erb, K. Thomas (Boston, MA, USA)

    Objective: To assess the utility of a cognitive and motor battery on a smartphone/smart watch combination in an at-home setting for remote assessment of PD…
  • 2019 International Congress

    Language characteristics of picture description task by Hebrew speaking patients with Parkinson’s disease

    D. Shpunt, S. Naor, N. Diamant, A. Faust-Socher, H. Shabtai, R. Peled, A. Migirov, T. Gurevich, Y. Manor (Tel Aviv, Israel)

    Objective: To characterize picture description by patients with PD Hebrew speakers. Background: Non-motor symptoms in Parkinson’s disease (PD) such as cognitive decline, depression and language…
  • 2019 International Congress

    Clinical Correlates of Genetic and Biomarker Profiles in Patients with Progressive Supranuclear Palsy: Data from the ARISE Study

    H. Soares, Z. Jin, N. Fisseha, M. Gold, C. Locke, B. Rendenbach-Mueller, E. Smith, I. Suridjan, A. Vasanthakumar, N. Mendonca (Ludwigshafen, Germany)

    Objective: To characterize the genetic and biomarker profile of patients with Progressive Supranuclear Palsy (PSP) and the relationship of potential biomarkers with baseline disease severity.…
  • 2019 International Congress

    Mechanisms underlying therapeutic group singing in persons with Parkinson’s disease

    E. Stegemoller, A. Zaman, K. Diaz, E. Shirtcliff, M. Kohut (Ames, IA, USA)

    Objective: The objective of this study was to examine the potential mechanisms associated with improvement in clinical motor symptoms in persons with Parkinson’s disease (PD).…
  • 2019 International Congress

    Effect of Medication Review on Reported Symptoms in Parkinson’s disease Patients

    C. Stuijt, T. Laar (Groningen, Netherlands)

    Objective: The objective was to analyse the effect of structured medication reviews (MR) in ambulatory PD patients on patient reported outcome measures (PROMS). Background: Patients…
  • 2019 International Congress

    Does information from the Personal KinetiGraph™ (PKG) influence neurologists´ treatment decisions?

    M. Sundgren, P. Rousu, A. Johansson (Stockholm, Sweden)

    Objective: To evaluate if PKG data influences neurologists´ treatment decisions in routine clinical care of patients with Parkinson´s disease. Background: The PKG movement recording system is…
  • 2019 International Congress

    Modeling of Parkinson’s disease by damaging dopaminergic neurons

    L. Toshpulatova, M. Kulmanova (Tashkent, Uzbekistan)

    Objective: Analysis of the simulation of Parkinson's disease in rats using 6-OHDA.Analysis of the simulation of Parkinson's disease in rats using 6-OHDA. Background: The mechanism…
  • 2019 International Congress

    Wide distribution of alpha-synuclein oligomers in Creutzfeldt-Jakob disease detected by a novel proximity ligation assay

    R. Valenti-Azcarate, I. Martinez-Valbuena, C. Caballero, I. Marcilla Garcia, G. Marti, M. Carmona-Abellan, M. Tuñon-Alvarez, MR. Luquin-Piudo (Pamplona, Spain)

    Objective: The objective of this work is to assess if oligomeric forms of alpha-synuclein exist in patients with Creutzfeldt-Jakob disease. Background: Prion diseases, the most…
  • 2019 International Congress

    Metabolomic Analysis of Fecal Matter from Parkinsonian Mice

    V. Vedam-Mai, E. Gill, J. Koelmel, R. Yost, T. Garrett, M. Okun (Gainesville, FL, USA)

    Objective: Assess the metabolic changes in fecal matter in mice treated with an immunomodulatory therapy. Background: The cause of neuronal death in Parkinson’s disease (PD)…
  • « Previous Page
  • 1
  • …
  • 1266
  • 1267
  • 1268
  • 1269
  • 1270
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley